Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation (Tables)

v3.22.4
Stock-based Compensation (Tables)
12 Months Ended
Jan. 01, 2023
Share-Based Payment Arrangement [Abstract]  
Common Stock Capital Shares Reserved for Future Issuance
The following table shows the shares of common stock that had been reserved for future issuance as of January 1, 2023.
Exercise of outstanding common stock options 5,034,282 
Options, RSUs and PRSUs available for future grants 22,972,236 
Outstanding RSUs and PRSUs for future vesting 7,371,158 
Common stock employee purchase plan available for future offerings 8,493,050 
43,870,726 
Stock-Based Compensation Expense
The following table summarizes the total stock-based compensation expense, by operating expense category, recognized in the Consolidated Statements of Operations and Comprehensive Loss for the periods presented below (in thousands).
Fiscal Years
2022 2021 2020
Cost of revenue $ 2,071  $ 274  $ 102 
Research and development 12,720  6,175  485 
Selling, general and administrative 15,576  4,262  79 
Total stock-based compensation expense $ 30,367  $ 10,711  $ 666 
Summary of Stock Option Activity
The following table summarizes stock option activities for the fiscal year January 1, 2023 (in thousands, except share and per share amount).
Number of
Options
Outstanding
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value (1) (2)
Balances as of January 2, 2022 5,753,005 $ 8.88 
Granted 56,190 14.56 
Exercised (381,497) 6.24  $ 4,258 
Forfeited (393,416) 9.79 
Balances as of January 1, 2023 5,034,282 $ 9.07  8.2 $ 18,486 
Vested and expected to vest at January 1, 2023 7,959,820 $ 5.76  8.1 $ 54,695 
Vested and exercisable at January 1, 2023 1,616,203 $ 8.32  8.0 $ 7,206 
Unvested and exercisable at January 1, 2023 3,197,163 $ 8.92  8.3 $ 11,249 
(1) The intrinsic value of options exercised is based upon the value of the Company’s stock at exercise.
(2)
The aggregate intrinsic value of the stock options outstanding as of January 1, 2023 represents the value of the Company’s closing stock price at $12.44 on January 1, 2023 in excess of the exercise price multiplied by the number of options outstanding.
Stock Option Valuation Assumptions
The Company uses the Black-Scholes option-pricing model to determine the grant date fair value of stock options with the following assumptions for the fiscal years 2022, 2021 and 2020.
Fiscal Years
2022 2021 2020
Risk-free interest rate
2.1% - 4.2%
0.5% - 1.3%
0.5  %
Expected term (years)
5.0 - 6.0
5.0 - 6.9
6.0
Dividend yield —  % —  % —  %
Expected volatility
67.6% - 70.1%
48.1% - 49.8%
37.8  %
RSUs and PRSUs Activity
The following table summarizes RSUs and PRSUs activities for the fiscal year January 1, 2023 (in thousands, except share and per share amount).
RSUs PRSUs
Number of
Shares
Outstanding
Weighted Average
Grant Date Fair Value
Number of
Shares
Outstanding
Weighted Average
Grant Date Fair Value
Issued and unvested shares balances as of January 2, 2022 535,449  $ 23.38  —  $ — 
Granted 6,497,482  13.65  1,500,845  13.41 
Vested (669,918) 15.40  —  — 
Forfeited (452,916) 16.64  (39,784) 13.41 
Issued and unvested shares outstanding as of January 1, 2023 5,910,097  $ 14.11  1,461,061  $ 13.41 
ESPP Valuation Assumptions
The Company uses the Black-Scholes option-pricing model to determine the fair value of estimated shares under the 2021 ESPP with the following assumptions for the fiscal years 2022 and 2021.
Fiscal Years
2022 2021
Risk-free interest rate
0.1% - 4.8%
0.1  %
Expected term (years)
0.5 - 1.5
0.5
Dividend yield
—%
—  %
Expected volatility
62.3% - 123.2%
71.5  %